logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10370358 B1

PDFFull Text
Date of Patent:
Aug. 06, 2019

Filed:

Feb. 22, 2018

Compounds for the treatment of hiv

Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Steven S. Bondy, Haiku, HI (US);

Carina E. Cannizzaro, Foster City, CA (US);

Chien-Hung Chou, Dublin, CA (US);

Randall L. Halcomb, Foster City, CA (US);

Yunfeng Eric Hu, San Mateo, CA (US);

John O. Link, San Francisco, CA (US);

Qi Liu, Union City, CA (US);

Scott D. Schroeder, Union City, CA (US);

Winston C. Tse, Redwood City, CA (US);

Jennifer R. Zhang, Union City, CA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:

Fish & Richardson P.C.

Primary Examiner:

Jean P Cornet

Int. Cl.
CPC ...
A61K 31/50 (2006.01); A61K 45/06 (2006.01); A61K 31/444 (2006.01); A61K 31/506 (2006.01); C07D 213/40 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 405/12 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01); C07D 471/06 (2006.01); C07D 487/04 (2006.01); C07D 491/04 (2006.01); C07D 495/04 (2006.01); A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/4709 (2006.01); A61K 31/4985 (2006.01); A61K 31/5377 (2006.01); C07D 491/052 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/4709 (2013.01); A61K 31/4985 (2013.01); A61K 31/50 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 213/40 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/12 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 471/06 (2013.01); C07D 487/04 (2013.01); C07D 491/04 (2013.01); C07D 491/052 (2013.01); C07D 495/04 (2013.01);
Abstract

The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.

Find Patent Forward Citations

Loading…